Breaking
Wednesday, July 8, 2026

News

🇺🇸 FDA Page 57

Latest pharmaceutical news, drug approvals, and FDA regulatory updates

Showing 673–684 of 807 articles

High impact NewsApr 17, 2026

Aicuris Receives FDA Priority Review for Pritelivir, Novel Herpes Treatment for Immunocompromised Patients

FDA · Antiviral - Herpes Simplex Virus Infections · 3 min

Dr. Sarah Mitchell
Critical impact NewsApr 17, 2026

Medera's AAV-SERCA2a Gene Therapy Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Cardiomyopathy

FDA · 2 min

James Chen, PharmD
High impact NewsApr 17, 2026

Boehringer Ingelheim's Zongertinib Shows Promise for HER2-Mutant Lung Cancer in NEJM Study

Non-small cell lung cancer (NSCLC) · 3 min

James Chen, PharmD
High impact NewsApr 17, 2026

FDA Approves MindBalance: First Digital Therapeutic for Anxiety, Depression

FDA · Anxiety · 8 min

Dr. Sarah Mitchell
High impact NewsApr 17, 2026

FDA Approves CancerVax for Adjuvant Melanoma Immunotherapy

FDA · Melanoma · 7 min

Dr. Sarah Mitchell
High impact NewsApr 17, 2026

FDA Approves PainBlock Patch: Novel Delivery System for Chronic Pain

FDA · Chronic Pain Management · 7 min

Dr. Sarah Mitchell
High impact NewsApr 17, 2026

FDA Approves RenalProtect for Diabetic Kidney Disease Treatment

FDA · Diabetic Kidney Disease · 5 min

Dr. Sarah Mitchell
High impact NewsApr 17, 2026

FDA Approves LungRx Inhaled Therapy: Breakthrough for Pulmonary Hypertension

FDA · Pulmonary Hypertension · 7 min

Dr. Sarah Mitchell
High impact NewsApr 16, 2026

FDA Updates Food Additive and Contact Substance Regulatory Timelines Through 2026

FDA · 2 min

Dr. Sarah Mitchell
High impact NewsApr 16, 2026

Re:Cognition Health Launches International Clinical Trial for Revolutionary Finger-Prick Alzheimer's Blood Test

Alzheimer's Disease Diagnostics · 3 min

James Chen, PharmD
High impact NewsApr 16, 2026

Sedogen Receives U.S. Patent for Diazoxide Treatment of Prader-Willi Syndrome Behavioral Symptoms

2 min

Dr. Sarah Mitchell
High impact NewsApr 16, 2026

Mabwell's LILRB4/CD3 Bispecific Antibody 6MW5311 Receives NMPA IND Approval for Leukemia Treatment

2 min

Dr. Sarah Mitchell